Surgical Innovations Group
Plc
("Surgical Innovations", the
"Company", or the "Group")
Directorate
Change
Appointment of Chief
Financial Officer
Commercially focused
MBA-qualified finance professional brings 20+ years of relevant
experience to the Group
Surgical Innovations Group Plc (AIM:
SUN), the designer, manufacturer and distributor of innovative
technology for minimally invasive surgery, announces the
appointment of Chris Martin as Chief Financial Officer ("CFO") and
an Executive Director of the Board,
effective Monday 10 June 2024. Chris takes over from Interim
Financial Consultant, Michael Roper, who will stay on to provide a
handover and facilitate a smooth transition.
Chris brings with him over 20 years'
experience as a Finance Director in various manufacturing
organisations. His most recent role was with Weir Plc, where he
served as Regional Finance Director for Europe, North Africa, and
Central Asia for six years. Prior to this, from 2004, Chris held
Finance Director positions with Jeld-Wen UK, Laing O'Rourke, The
Latium Group, and Lafarge S.A.. He obtained an MBA in 2014 and
began his finance career in Lafarge Roofing Ltd (part of Lafarge
S.A, formerly Redland Plc) in 1990.
CEO, David Marsh, commented:
"Chris brings a wealth of experience in growing and improving
business performance, managing change, implementing new systems,
and developing high-performing teams. We are
confident that
his expertise and leadership will be valuable to Surgical
Innovations as we continue to drive our strategic initiatives
forward.
"We would also like to take this opportunity to thank Michael
Roper, our Interim Financial Consultant, for his guidance and
advice over the past few months."
The following details are disclosed
pursuant to Schedule Two Paragraph (g) of the AIM Rules for
Companies:
Christopher
("Chris") Jonathan Martin, age
55, holds or has held the following
directorships in the past five years:
Current Directorships
|
None
|
Directorships held within the last five
years
|
Weir Mineral Europe Limited
|
There are no further disclosures
required to be made in relation to AIM Rule 17.
For further information please
contact:
Surgical Innovations Group
plc
|
www sigroupplc
com
|
David Marsh, CEO
Chris
Martin, CFO
|
Tel: 0113
230 7597
|
|
|
Singer
Capital Markets (Nominated Adviser & Broker)
|
Tel: 020
7496 3000
|
Aubrey Powell / Oliver
Platts
|
|
|
|
Walbrook PR (Financial PR &
Investor Relations)
|
Tel: 020
7933 8780 or si@walbrookpr.com
|
Paul McManus / Charlotte
Edgar
|
Mob: 07980
541 893 / 07884 664 686
|
|
|
| |
About Surgical Innovations Group
plc
The Group specialises in the design,
manufacture, sale and distribution of innovative, high quality
medical products, primarily for use in minimally invasive surgery.
Our product and business development is guided and supported by a
key group of nationally and internationally renowned surgeons
across the spectrum of minimally invasive surgical
activity.
We design and manufacture and source
our branded port access systems, surgical instruments and
retraction devices which are sold directly in the UK home market
through our subsidiary, Elemental Healthcare, and exported widely
through a global network of trusted distribution partners. Many of
our products in this field are based on a "resposable" concept, in
which the products are part reusable, part disposable, offering a
high quality and environmentally responsible solution at a cost
that is competitive against fully disposable
alternatives.
Elemental also has exclusive UK
distribution for a select portfolio of specialist products employed
in laparoscopy, bariatric and metabolic surgery, hernia repair and
breast reconstruction.
In addition, we design and develop
medical devices for carefully selected OEM partners and have also
collaborated with a major UK industrial partner to provide
precision engineering solutions to complex problems outside the
medical arena.
We aim for our brands to be
recognised and respected by healthcare professionals in all major
geographical markets in which we operate and provide by
development, partnership or acquisition a broad portfolio of cost
effective, procedure specific surgical instruments and implantable
devices that offer reliable solutions to genuine clinical needs in
the operating theatre environment.
Further information
Further details of the Group's
businesses and products are available on the following
websites:
www.sigroupplc.com
www.surginno.com
www.elementalhealthcare.co.uk
To receive regular updates by email,
please contact si@walbrookpr.com